Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

BACKGROUND: Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Belmonte, Luis M., Torres-Peña, José David, López-Carmona, María D., Ayala-Gutiérrez, M. Mar., Fuentes-Jiménez, Francisco, Huerta, Lucía Jorge, Muñoz, Jaime Alonso, Rubio-Rivas, Manuel, Madrazo, Manel, Garcia, Marcos Guzmán, Montes, Beatriz Vicente, Sola, Joaquim Fernández, Ena, Javier, Ferrer, Ruth Gonzalez, Pérez, Carmen Mella, Ripper, Carlos Jorge, Lecumberri, Jose Javier Napal, Acedo, Iris El Attar, Canteli, Susana Plaza, Cosío, Sara Fuente, Martínez, Francisco Amorós, Rodríguez, Begoña Cortés, Pérez-Martínez, Pablo, Ramos-Rincón, José Manuel, Gómez-Huelgas, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666969/
https://www.ncbi.nlm.nih.gov/pubmed/33190637
http://dx.doi.org/10.1186/s12916-020-01832-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666969/
https://www.ncbi.nlm.nih.gov/pubmed/33190637
http://dx.doi.org/10.1186/s12916-020-01832-2

Ejemplares similares